ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1944

Enhancing Rheumatology Consultations with AI-Powered Triage: The ReumAI Pilot Study

Antonio Gomez-Centeno1, Mariña Sabaris-Vilas2, Javier Segura-Sanchez3 and Fermin Garcia-Sancho3, 1Hospital Quiron Barcelona, Barcelona, Spain, 2Hospital Quirón Barcelona, Barcelona, Spain, 3TamoeInnovation S.L., Madrid, Spain

Meeting: ACR Convergence 2024

Keywords: Access to care, informatics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Health Services Research – ACR/ARP Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: In private healthcare settings, patients often have direct access to specialists without prior referral. However, in rheumatology, this can lead to inefficiencies due to the wide range of conditions and a general lack of knowledge about the specialty. Initial consultations often don’t result in a definitive diagnosis or treatment plan, leading to additional tests and follow-up visits, which prolongs time to diagnosis and treatment, increases waiting lists, and creates inefficiencies for patients, insurers, and healthcare providers.

Objective: To evaluate the effectiveness of ReumAI, an artificial intelligence (AI)-based triage system, in optimizing rheumatology consultations in a private hospital setting.

Methods: A pilot study was conducted at the rheumatology department of Hospital Quirón Barcelona, where all new patient requests were managed using ReumAI. This system, operated by non-physician healthcare staff, conducts an AI-guided telephone interview to obtain a syndromic diagnostic orientation and determine necessary tests before the specialist visit. The first 300 patients managed with this system were analyzed, evaluating diagnostic concordance and the utility of requested tests.

Results: The mean patient age was 52 years (SD 14), with 72% being women. The most frequent reasons for consultation were hand pain (28%), nonspecific pain (25%), and foot pain (11%). The final syndromic diagnosis was included in ReumAI’s differential diagnosis in 85% of cases, with a moderate correlation (53%) between ReumAI’s syndromic diagnosis and the rheumatologist’s diagnosis. Tests ordered by ReumAI were useful in most cases (95%).

Conclusion: ReumAI shows promise as a tool for optimizing rheumatology triage, potentially improving consultation efficiency and reducing wait times. Larger-scale studies are needed to confirm these findings and assess the long-term impact on patient care.


Disclosures: A. Gomez-Centeno: None; M. Sabaris-Vilas: None; J. Segura-Sanchez: None; F. Garcia-Sancho: None.

To cite this abstract in AMA style:

Gomez-Centeno A, Sabaris-Vilas M, Segura-Sanchez J, Garcia-Sancho F. Enhancing Rheumatology Consultations with AI-Powered Triage: The ReumAI Pilot Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/enhancing-rheumatology-consultations-with-ai-powered-triage-the-reumai-pilot-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/enhancing-rheumatology-consultations-with-ai-powered-triage-the-reumai-pilot-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology